Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2004 1
2014 1
2015 2
2017 1
2019 1
2020 3
2021 1
2022 1
2023 1
2024 1
2025 5
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Distinct cell state ecosystems for nodular lymphocyte-predominant Hodgkin lymphoma.
Subramanian A, Su S, Flerlage J, Alig S, Younes S, Marks LJ, Pinnix C, Vega F, Steiner R, Kumar P, Mocikova H, Sykorova A, Prochazka V, Milito C, Allen P, Paulino D, Ramsay A, Flerlage T, Palese M, West R, Zhu C, Noordenbos T, Schroers-Martin J, Zhao S, Park NJ, Kalbasi A, Moding EJ, Newman AM, Advani RH, Hoppe RT, Diehn M, Natkunam Y, Alizadeh AA, Binkley MS. Subramanian A, et al. Nat Commun. 2025 Sep 26;16(1):8473. doi: 10.1038/s41467-025-63339-9. Nat Commun. 2025. PMID: 41006203 Free PMC article.
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapy.
Jiang H, Limsuwannarot S, Kulhanek KR, Pal A, Rysavy LW, Su L, Labiad O, Testa S, Ogana H, Waghray D, Tao P, Jude KM, Seet CS, Crooks GM, Moding EJ, Garcia KC, Kalbasi A. Jiang H, et al. bioRxiv [Preprint]. 2025 Jan 19:2025.01.15.633105. doi: 10.1101/2025.01.15.633105. bioRxiv. 2025. Update in: Immunity. 2026 Jan 13;59(1):177-194.e12. doi: 10.1016/j.immuni.2025.10.024. PMID: 39868284 Free PMC article. Updated. Preprint.
Antitumor Immune Responses in B2M-Deficient Cancers.
Torrejon DY, Galvez M, Abril-Rodriguez G, Campbell KM, Medina E, Vega-Crespo A, Kalbasi A, Comin-Anduix B, Ribas A. Torrejon DY, et al. Cancer Immunol Res. 2023 Dec 1;11(12):1642-1655. doi: 10.1158/2326-6066.CIR-23-0139. Cancer Immunol Res. 2023. PMID: 37801341 Free PMC article.
Evolutionary Pressures Shape Undifferentiated Pleomorphic Sarcoma Development and Radiotherapy Response.
Blomain ES, Soudi S, Wang Z, Somani A, Subramanian A, Nouth SCL, Oladipo E, New C, Kenney DE, Nemat-Gorgani N, Kindler T, Avedian RS, Steffner RJ, Mohler DG, Hiniker SM, Chin AL, Kalbasi A, Binkley MS, Fried M, Gaida MM, van de Rijn M, Moding EJ. Blomain ES, et al. Cancer Res. 2025 Mar 14;85(6):1162-1174. doi: 10.1158/0008-5472.CAN-24-3281. Cancer Res. 2025. PMID: 39808162 Free PMC article.
Microfluidic Brain-on-a-Chip: Perspectives for Mimicking Neural System Disorders.
Mofazzal Jahromi MA, Abdoli A, Rahmanian M, Bardania H, Bayandori M, Moosavi Basri SM, Kalbasi A, Aref AR, Karimi M, Hamblin MR. Mofazzal Jahromi MA, et al. Mol Neurobiol. 2019 Dec;56(12):8489-8512. doi: 10.1007/s12035-019-01653-2. Epub 2019 Jul 1. Mol Neurobiol. 2019. PMID: 31264092 Free PMC article. Review.
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 results.
Deng J, Pal A, Testa S, Xu JW, Tran LM, Graham DS, Hargil A, Subramanian A, Campbell KM, Limsuwannarot S, Chumpitaz Lavalle Á, Chin SC, Kremer S, Tariveranmoshabad M, Ewongwo A, Silvia SNR, Ogana H, Nemat-Gorgani N, Dubinett SM, Jaycox JR, Felix C, Schaue D, Nelson SD, Levine B, Motamedi K, Ghazikhanian V, Chmielowski B, Reddy V, Singh AS, Trnkova ZJ, Good Z, Quintero M, Crompton JG, Bernthal N, Eilber FC, Moding EJ, Kalbasi A. Deng J, et al. Cancer Discov. 2026 Mar 5:10.1158/2159-8290.CD-25-1132. doi: 10.1158/2159-8290.CD-25-1132. Online ahead of print. Cancer Discov. 2026. PMID: 41784328 Free PMC article.
Engineered IL13 variants direct specificity of IL13Rα2-targeted CAR T cell therapy.
Stern LA, Gholamin S, Moraga I, Yang X, Saravanakumar S, Cohen JR, Starr R, Aguilar B, Salvary V, Hibbard JC, Kalbasi A, Shepphird JK, O'Hearn J, Garcia KC, Brown CE. Stern LA, et al. Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2112006119. doi: 10.1073/pnas.2112006119. Epub 2022 Aug 8. Proc Natl Acad Sci U S A. 2022. PMID: 35939683 Free PMC article.
18 results